Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use in ...
Adding $83.6 Million in Annual Revenue Starting in Q1’26OREM, Utah, Nov. 11, 2025 (GLOBE NEWSWIRE) -- SunPower (herein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback